US 12397013
Extrahepatic delivery
granted A61KA61K31/713A61K47/543
Quick answer
US patent 12397013 (Extrahepatic delivery) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 66
- CPC classes
- A61K, A61K31/713, A61K47/543, A61K47/549, A61K47/55